why do people stop taking glp 1 drugs patients GLP-1 drugs? Half of GLP-1 users ditch

10.1038/s41419-021-04227-0 24 KuboH.AsaiK.KojimaK.SugitaniA.KyomotoY.OkamotoA.et al (2019)

Standard or sample was transferred in triplicate to a 96-well plate and GSH was then derivitized by the addition of 10 mM 2,3-naphthalenedicarboxyaldehyde and the fluorescence at Ex/Em wavelength of 472/528 nm was quantified using a fluorescent plate reader (Synergy 2, BioTek)

Pharmacokinetics When analyzing the use of GLP-1 receptor agonists and their doses in the management of AUD, providers must consider multiple factors, including age, medical history, current medications, comorbid conditions, metabolic state, response to therapy, side effect profile, and potential risks and benefits for each individual

Phytomedicine 69, 153202

Mizushima N

It is an elongation of the famous peptide Argireline (Acetyl Hexapeptide-8)